CORRESP Filing
REGENXBIO Inc.
Date: Dec. 9, 2025 · CIK: 0001590877 · Accession: 0001193125-25-312817
AI Filing Summary & Sentiment
File numbers found in text: 333-291816
Show Raw Text
CORRESP 1 filename1.htm CORRESP December 9, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Tim Buchmiller Re: REGENXBIO Inc. (the “Company”) Registration Statement Filed on Form S-3 (the “Registration Statement”) File No. 333-291816 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on December 12, 2025, or as soon as practicable thereafter. Please contact Mathew C. Franker of Covington & Burling LLP at (202) 662-5895 or mfranker@cov.com with any questions you may have regarding this request. In addition, please notify Mr. Franker by telephone when this request for acceleration has been granted. Respectfully, REGENXBIO Inc. By: /s/ Patrick Christmas Name: Patrick Christmas Title: Executive Vice President, Chief Legal Officer cc: Mathew C. Franker, Covington & Burling LLP